Detail akcie HISAMITSU PHARM online

Business Summary: Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
Financial Summary: BRIEF: For the fiscal year ended 28 February 2025, Hisamitsu Pharmaceutical Co Inc revenues increased 10% to Y156.01B. Net income applicable to common stockholders increased 56% to Y21.76B. Revenues reflect USA segment increase of 25% to Y38.89B, Other segment increase of 17% to Y34.75B. Net income benefited from Gain On Sales Of Investment Securities increase from Y389M to Y5.02B (income).